Abstract: In one embodiment, a method includes receiving current session information associated with a first user from a beacon associated with a third-party content provider, wherein the current session information indicates that a first client system of the first user is in an active wireless communication session with the beacon, accessing session information associated with one or more second users, wherein each second user is within a threshold geographical distance of the beacon, selecting one or more of the one or more second users based on the accessed session information, wherein the accessed session information associated with each of the selected second users indicates that a second client system associated with the selected second user is not in a wireless communication session with the beacon, and sending a notification referencing the selected one or more second users to the first client system.

Abstract: An integrated circuit die, a semiconductor structure, and a method of fabricating the semiconductor structure are disclosed. The integrated circuit die includes a substrate and a first anchor and a second anchor disposed on the substrate in a first plane. The integrated circuit die also includes a first wire disposed on the first anchor in the first plane, a third wire disposed on the second anchor in the first plane, and a second wire and a fourth wire suspended above the substrate in the first plane. The second wire is disposed between the first wire and the third wire and the third wire is disposed between the second wire and the fourth wire. The integrated circuit die further includes a dielectric material disposed between upper portions of the first wire, the second wire, the third wire, and the fourth wire to encapsulate an air gap.

Abstract: The present invention provides pharmaceutical composition of antineoplastic alkylating agent in oral suspension dosage form. The oral suspension composition comprises of alkylating agent with other pharmaceutical excipients such as vehicle, preservative, antioxidant, suspending agent, surfactant, sweetener and flavouring agent. The present invention is an oral suspension having improved stability and palatability. The present invention also provides oral solution with flavor that has masked bitter taste of the drug. Further, the present invention also provides a process for preparation thereof.

Abstract: Systems and methods described herein provide a network tool that discovers device configurations for selected enterprise sites and automatically organizes the data to assist users, so they can build intents for network function policies in enterprise networks. An intent builder performs device discovery of network function (NF) instances in a customer network; retrieves configuration elements from the NF instances; normalizes the configuration elements; and generates a graphical user interface with rule paths based on the configuration elements. The network device receives, via the graphical user interface, user input to map source Internet protocol (IP) addresses in the rule paths to a user label and to map destination IP address in the rule paths to an application label. Based on the user input, the network device presents, via the graphical user interface, consolidated intents and generates vendor-agnostic policy rules from the consolidated intents.

Abstract: Embodiments of the present disclosure are directed to hydrogen-selective oxygen carrier materials and methods of using hydrogen-selective oxygen carrier materials. The hydrogen-selective oxygen carrier material may comprise a core material, which includes a redox-active transition metal oxide; a shell material, which includes one or more alkali transition metal oxides; and a support material. The shell material may be in direct contact with at least a majority of an outer surface of the core material. At least a portion of the core material may be in direct contact with the support material. The hydrogen-selective oxygen carrier material may be selective to combust hydrogen in an environment that includes hydrogen and hydrocarbons.

Abstract: A chum predictor predicts whether a customer is likely to chum. The chum predictor is built and trained from data collected from mul-tiple customers. The data can include static configuration data and dynamic measured data. A chum predictor builder generates multiple customer in-stances and processes the instances based on the collected data, and based on separating the instances into one or more training subsets. Based on the pro-cessing, the builder generates and saves a chum predictor. The chum predictor can access data for a customer and generate a customer instancance and generates a chum likelihood score. Based on a chum type, the chum predictor system can generate preventive action for the customer.

Abstract: An access control system that includes an access control device configured to receive transaction information that identifies a member identifier for a member and a purchased item. The access control device is configured to compare the purchased item to items in an item list and to determine whether the purchased item matches any items in the item list. The access control device is configured to store an authorization for the member identifier to access an augmented reality experience in response to a match.

Abstract: A method begins by a processing module of a storage network analyzing storage network memory for a level of usability and based on the analyzing, selecting alternative memory available for receipt of encoded data slices stored in current memory, where a data object is segmented into a plurality of data segments and a data segment of the plurality of data segments is dispersed error encoded in accordance with dispersed error encoding parameters to produce a set of encoded data slices. The method continues with the processing module determining whether to move encoded data slices from current memory to alternative memory and based on a determination to move slices, allocating alternative memory. Finally, the processing module moves at least some encoded data slices from a current memory to alternate memory and updates a memory assignment mechanism for the at least some encoded data slices.

Abstract: Compositions comprising Group V/III nanowires, and methods of making such nanowires are described. Some compositions comprise one or more core-shell nanowires comprising a core and a first shell surrounding or substantially surrounding the core. The core is formed from GaAs(1-y)Sby, where y=about 0.03-0.07 and the first shell is formed from GaAs(1-x)SbxN, where x=0.27-0.34. The nanowires have an average emission maximum of 1.4-1.7 ?m. Some nanowires further comprise a second shell surrounding or substantially surrounding the first shell. The second shell is formed from a Group V/III material such as Ga1-mAlmAs, where m=0-0.2. Some nanowires have the structure GaAs(0.93-0.97)Sb(0.03-0.07)/GaAs(0.66-0.73)Sb(0.27-0.34)N/Ga(0.8-1)Al(0-0.2)As.

Abstract: A method for facilitating synchronization of a remote file system (RFS) and a local file system (LFS) includes maintaining a global revision identifier associated with the RFS, where the global revision identifier has a variable state, and responsive to the RFS being modified, updating metadata associated with one or more of the file system objects of the RFS based on a state of the global revision identifier. More particularly, the method includes updating the global revision identifier to a new state in response to the RFS modification and then updating the metadata of the folder(s) associated with the RFS modification. The RFS metadata is partitioned by folder and file to facilitate efficient searching based on a requested namespace view. Another method utilizes prior revision identifiers stored in the LFS to limit the RFS metadata returned to the local cloud during a rescan, by excluding the data set that has not changed, which improves the efficiency of the rescan synchronization.

Abstract: An oral pharmaceutical composition in unit dosage form comprising: (1) a first portion comprising: an active ingredient and a pH-dependent component, and (2) a second portion comprising a pH-raising agent is provided. Methods of administering the composition are also provided.

Abstract: The disclosed technology relates to a load balancing system. A load balancing system is configured to receive health monitoring metrics, at a controller, from a plurality of leaf switches. The load balancing system is further configured to determine, based on the health monitoring metrics, that a server has failed and modify a load balancing configuration for the network fabric. The load balancing system is further configured to transmit the load balancing configuration to each leaf switch in the network fabric and update the tables in each leaf switch to reflect an available server.

Abstract: Mobile devices executing applications utilize data services worldwide, with issues involving the transfer of data on the network impacting the operation and user experience of those applications. Network data is acquired from a mobile computing device during communication and processed to determine occurrence of a burst which is representative of elements in the network data that are determined to be causally related. Bursts are analyzed, and those associated with poor performance are presented in a user interface. The user interface provides impact information about the effect the burst had on operation of the application. The user interface may provide suggestions to mitigate the poor performance. If no problem is determined by the system, but the user believes a problem to have occurred, user input is collected and used to trigger a workflow to analyze the burst. Subsequent results of this analysis are returned to the user via the user interface.

Abstract: Systems and methods for proactive transfer of stored data between storage zones to avoid anticipated bit rot are provided. In embodiments, a method includes: determining that one or more quality prediction parameters of a storage zone of a data storage device meet a predetermined threshold for user access or adjacency to another storage zone determined to be unhealthy; and initiating a proactive refreshing of the storage zone based on the determining that the storage zone meets the predetermined threshold, the proactive refreshing of the storage zone including: reading all data in the storage zone; determining that no errors have occurred during the reading of the data; and based on the determination that no errors have occurred, moving all of the data of the storage zone to a new storage zone.

Abstract: Silane-crosslinkable polymeric compositions comprising a polyolefin having hydrolyzable silane groups, an acidic silanol condensation catalyst, and a phenolic antioxidant. The phenolic antioxidant has a phenol-based moiety fused with a cyclic ether where the oxygen atom of the cyclic ether is located in the para position relative to the hydroxyl group of the phenol-based moiety. Such crosslinkable polymeric compositions can be employed in various articles of manufacture, such as in the wire and cable industry.

Abstract: A device may receive issue resolution information, associated with a cognitive model, including an item of issue resolution information that describes an issue and a resolution to the issue. The device may assign the item of issue resolution information to a domain hierarchy, where the assigning is associated with a first user. The device may generate a question and an answer corresponding to the item of issue resolution information, where the generating of the question and the answer is associated with a second user. The device may approve the question and the answer, where the approving is associated with a third user. The device may generate a question/answer (QA) pair for the question and the answer. The device may create a data corpus including the QA pair, and provide the data corpus to cause the cognitive model to be trained based on the data corpus.

Abstract: Embodiments herein describe using compression engines in a processor subsystem to compress only the data fragments stored locally. That is, an application may be allocated a buffer where the physical memory of that buffer is spread across multiple processor subsystems. Rather than asking a single actor (e.g., a single host processor or compression engine) to compress all the fragments of the buffer, a compression library can instead instruct the individual compression engines in each of the processor subsystems to compress only the fragments stored in local memory in the same processor subsystem. Doing so leverages the memory affinity between the compression engines in the local memory which can reduce the overall time required to perform compression.

Abstract: Systems and methods are disclosed for directed image capture of a subject of interest, such as a home. Directed image capture can produce higher quality images such as more centrally located within a display and/or viewfinder of an image capture device, higher quality images have greater value for subsequent uses of captured images such as for information extraction or model reconstruction. Graphical guide(s) facilitate content placement for certain positions and quality assessments for the content of interest can be calculated such as for pixel distance of the content of interest to a centroid of the display or viewfinder, or the effect of obscuring objects. Quality assessments can further include instructions for improving the quality of the image capture for the content of interest.

Abstract: Various circuit board embodiments are disclosed. In one aspect, an apparatus is provided that includes a circuit board and a first phase change material pocket positioned on or in the circuit board and contacting a surface of the circuit board.

Abstract: Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the active pharmaceutical ingredient is selected from quetiapine, sildenafil, tadalafil, cinacalcet, ticagrelor, mycophenolate, aprepitant, zonisamide, and primidone.